Abstract
Objectives The causal associations of physical activity and sedentary behavior with the risk of gastrointestinal disease is unclear. We performed a Mendelian randomization analysis to examine these associations.
Methods Genetic instruments associated with leisure screen time (LST, an indicator of a sedentary lifestyle) and moderate-to-vigorous intensity physical activity (MVPA) at the genome-wide significance (P<5×10−8) level were selected from a genome-wide association study (N<703,901). Summary statistics for gastrointestinal diseases were obtained from the UK Biobank study (N>330,000), the FinnGen study (N>220,000), and large consortia. Multivariable MR analyses were conducted for genetically determined LST with adjustment for MVPA and vice versa. We also performed multivariable MR with adjustment for genetically proxied smoking, body mass index (BMI), fasting insulin, and type 2 diabetes for both exposures.
Results Genetically proxied longer LST was associated with increased risk of gastrointestinal reflux, gastric ulcer, duodenal ulcer, chronic gastritis, irritable bowel disease, diverticular disease, Crohn’s disease, non-alcoholic fatty liver disease, alcoholic liver disease, cholecystitis, cholelithiasis, acute pancreatitis, chronic pancreatitis, and acute appendicitis. Most associations remained after adjustment for genetic liability to MVPA. Genetic liability to MVPA was associated with decreased risk of gastroesophageal reflux, gastric ulcer, chronic gastritis, irritable bowel syndrome, cholelithiasis, and acute pancreatitis. The associations attenuated albeit directionally remained after adjusting for genetically predicted LST. Multivariable MR analysis found that BMI and type 2 diabetes mediated the associations of LST and MVPA with several gastrointestinal diseases.
Conclusion The study suggests that a sedentary lifestyle may play a causal role in the development of many gastrointestinal diseases.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
XL is supported by the Natural Science Fund for Distinguished Young Scholars of Zhejiang Province (LR22H260001). MZD is supported by Natural Science Foundation of Hunan Province (2021JJ30999); SCL is supported by the Swedish Heart Lung Foundation (20210351), the Swedish Research Council (2019-00977), and the Swedish Cancer Society (Cancerfonden). SB is supported by the Wellcome Trust (225790/7/22/Z) and the United Kingdom Research and Innovation Medical Research Council (MC_UU_00002/7). This research was supported by the National Institute for Health Research Cambridge Biomedical Research Centre (NHIR203312). The views expressed are those of the authors and not necessarily those of the National Institute for Health Research or the Department of Health and Social Care. Funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or the decision to submit the manuscript for publication.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
1. FinnGen: Unique genetic insights from combining isolated population and national health register data. https://www.finngen.fi/en 2. Scalable generalized linear mixed model for region-based association tests in large biobanks and cohorts. PMID: 32424355 3. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. PMID: 26192919 4. Genome-wide association analyses of physical activity and sedentary behavior provide insights into underlying mechanisms and roles in disease prevention. PMID: 36071172
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵# Joint first authors
Data Availability
Data can be obtained upon a reasonable request to corresponding authors.
